» Articles » PMID: 31212809

Roles of E-cadherin and Noncoding RNAs in the Epithelial-mesenchymal Transition and Progression in Gastric Cancer

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Jun 20
PMID 31212809
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

The epithelial-mesenchymal transition (EMT) is thought to be at the root of invasive and metastatic cancer cell spreading. E-cadherin is an important player in this process, which forms the structures that establish and maintain cell-cell interactions. A partial or complete loss of E-cadherin expression in the EMT is presumably mediated by mechanisms that block the expression of E-cadherin regulators and involve the E-cadherin-associated transcription factors. The protein is involved in several oncogenic signaling pathways, such as the Wnt/β-catenin, Rho GTPase, and EGF/EGFR, whereby it plays a role in many tumors, including gastric cancer. Such noncoding transcripts as microRNAs and long noncoding RNAs-critical components of epigenetic control of gene expression in carcinogenesis-contribute to regulation of the E-cadherin function by acting directly or through numerous factors controlling transcription of its gene, and thus affecting not only cancer cell proliferation and metastasis, but also the EMT. This review focuses on the role of E-cadherin and the non-coding RNAs-mediated mechanisms of its expressional control in the EMT during stomach carcinogenesis.

Citing Articles

Integrative bioinformatics analysis of high-throughput sequencing and in vitro functional analysis leads to uncovering key hub genes in esophageal squamous cell carcinoma.

Shen F, Liu X, Ding F, Yu Z, Shi X, Cheng L Hereditas. 2025; 162(1):38.

PMID: 40087784 DOI: 10.1186/s41065-025-00398-4.


Homoharringtonine: mechanisms, clinical applications and research progress.

Wang W, He L, Lin T, Xiang F, Wu Y, Zhou F Front Oncol. 2025; 15:1522273.

PMID: 39949739 PMC: 11821653. DOI: 10.3389/fonc.2025.1522273.


Highly expressed B3GALT5-AS1 contributes to gastric cancer progression by recruiting WDR5 to mediate B3GALT5 and regulating β-catenin/ZEB1 axis.

Feng W, Tang Y, Jing R, Ju S, Zong W J Cell Mol Med. 2024; 28(17):e70061.

PMID: 39224045 PMC: 11369489. DOI: 10.1111/jcmm.70061.


Notch1 signaling pathway promotes growth and metastasis of gastric cancer via modulating CDH5.

Zhou L, Yang Y, Ye Y, Qiao Q, Mi Y, Liu H Aging (Albany NY). 2024; 16(16):11893-11903.

PMID: 39172098 PMC: 11386911. DOI: 10.18632/aging.206061.


The regulatory mechanism of m6A modification in gastric cancer.

Wu S, Li C, Zhou H, Yang Y, Liang N, Fu Y Discov Oncol. 2024; 15(1):283.

PMID: 39009956 PMC: 11250764. DOI: 10.1007/s12672-024-00994-2.


References
1.
Suriano G, Oliveira M, Huntsman D, Mateus A, Ferreira P, Casares F . E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet. 2003; 12(22):3007-16. DOI: 10.1093/hmg/ddg316. View

2.
Cavallaro U, Christofori G . Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2004; 4(2):118-32. DOI: 10.1038/nrc1276. View

3.
Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y . Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun. 2004; 315(3):686-91. DOI: 10.1016/j.bbrc.2004.01.108. View

4.
Kuphal S, Poser I, Jobin C, Hellerbrand C, Bosserhoff A . Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene. 2004; 23(52):8509-19. DOI: 10.1038/sj.onc.1207831. View

5.
Mattick J, Makunin I . Non-coding RNA. Hum Mol Genet. 2006; 15 Spec No 1:R17-29. DOI: 10.1093/hmg/ddl046. View